Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2945-2950
Published online before print November 13, 2003, doi: 10.1161/01.STR.0000103137.44496.AD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/12/2945    most recent
01.STR.0000103137.44496.ADv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camilo, O.
Right arrow Articles by Goldstein, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camilo, O.
Right arrow Articles by Goldstein, L. B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Thrombolysis
Right arrow Carotid endarterectomy

(Stroke. 2003;34:2945.)
© 2003 American Heart Association, Inc.


Original Contributions

Statewide Assessment of Hospital-Based Stroke Prevention and Treatment Services in North Carolina

Changes Over the Last 5 Years

Osvaldo Camilo, MD Larry B. Goldstein, MD

From the Department of Medicine (Neurology) (O.C., L.B.G.), Duke Center for Cerebrovascular Disease (O.C., L.B.G.), and Stroke Policy Program, Center for Clinical Health Policy Research (L.B.G.), Duke University, and the Durham VA Medical Center (L.B.G.), Durham, NC.

Correspondence to Larry B. Goldstein, MD, Director, Duke Center for Cerebrovascular Disease, Head, Stroke Policy Program, Center for Clinical Health Policy Research, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004{at}mc.duke.edu

Background and Purpose— The first published statewide assessment of stroke prevention and treatment services in the United States was carried out in North Carolina in 1998. The purpose of the present study was to measure changes in these services that may have occurred over the last 5 years.

Methods— A 1-page questionnaire was sent to each facility in the state in February 2003. Results were compared with the 1998 survey.

Results— Complete responses were obtained from each of the state’s 128 facilities. The proportions of hospitals providing CT angiography (35% versus 55%, P<=0.01), diffusion-weighted MRI (20% versus 45%, P<=0.01), transesophageal echocardiography (45% versus 59%, P<=0.02), and inpatient rehabilitation services (25% versus 43%, P<=0.01) increased over the 5 years. There was a trend toward more facilities having tissue plasminogen activator protocols (43% versus 54%, P<=0.09) but a decrease in the proportion of hospitals with interventional radiologists (23% versus 15%, P<0.01). There was no change in the proportion of the state’s population living in a county with a basic stroke prevention and treatment center, with the proportion residing in a county with an advanced center increasing by 12%. Entire regions of the state lacked either type of center, and only 14% had even the essential infrastructure recommended for a Brain Attack Coalition–type primary stroke center. There was no difference in the proportions of hospitals with organized stroke teams, those having a stroke acute care unit, those using stroke care maps, or hospitals having community awareness programs.

Conclusions— Certain technologies have become more widely available, but hospital investments in stroke-related programs have not appreciably increased.


Key Words: cerebrovascular disorders • data collection • diagnosis • emergency medical services • primary prevention • thrombolytic therapy




This article has been cited by other articles:


Home page
CirculationHome page
D. C. Goff Jr, L. Brass, L. T. Braun, J. B. Croft, J. D. Flesch, F. G.R. Fowkes, Y. Hong, V. Howard, S. Huston, S. F. Jencks, et al.
Essential Features of a Surveillance System to Support the Prevention and Management of Heart Disease and Stroke: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease
Circulation, January 2, 2007; 115(1): 127 - 155.
[Full Text] [PDF]


Home page
StrokeHome page
M. I. Weintraub
Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke, July 1, 2006; 37(7): 1917 - 1922.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. L. Birbeck, D. S. Zingmond, X. Cui, and B. G. Vickrey
Multispecialty stroke services in California hospitals are associated with reduced mortality
Neurology, May 23, 2006; 66(10): 1527 - 1532.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. B. Goldstein and D. L. Simel
Is This Patient Having a Stroke?
JAMA, May 18, 2005; 293(19): 2391 - 2402.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. Camilo and L. B. Goldstein
Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey
Neurology, February 22, 2005; 64(4): 762 - 763.
[Full Text] [PDF]


Home page
NeurologyHome page
February 8 Highlight and Commentary: Criteria for stroke centers
Neurology, February 8, 2005; 64(3): 403 - 403.
[Full Text] [PDF]


Home page
StrokeHome page
V. Aiyagari, A. Gujjar, A. R. Zazulia, and M. N. Diringer
Hourly Blood Pressure Monitoring After Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Does Everyone Need It?
Stroke, October 1, 2004; 35(10): 2326 - 2330.
[Abstract] [Full Text] [PDF]